Literature DB >> 26429311

SOCS3 and its role in associated diseases.

Yanlin Yin1, Weiwei Liu1, Yalei Dai2.   

Abstract

Cell-cell communication depends on cytokine and growth factor network. Bound to their receptors on the surface of target cell, these glycoproteins initiate a range of intracellular events. Subsequent dissipation of receptor signaling is essential to ensure the response of the cell does not become pathogenic. The Suppressors of cytokine signaling (SOCS) proteins are a family of proteins induced to attenuate cytokine signal transduction in response to signals from a diverse range of cytokines and growth factors. Current evidence indicates that intracellular JAK-STAT (Janus kinase-signal transducer and activator of transcription) signaling not only governs cytokine-induced immunological responses but also rapidly initiates SOCS expression and its biological functions. This review focuses on current understanding of SOCS3, a member of SOCS family. SOCS3 binds to JAK, certain cytokine receptors in intracellular domain, and some signaling molecules, which results in suppressing further signaling events in the cell. Studies using conditional knockout mice have shown that SOCS3 protein is the key physiological regulator and plays an important pathological role in immune homeostasis. Dysregulation of SOCS3 functions can cause a variety of diseases, including allergy, autoimmune diseases, inflammation and cancer.
Copyright © 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine; Immune homeostasis; JAK–STAT signaling; SOCS3

Mesh:

Substances:

Year:  2015        PMID: 26429311     DOI: 10.1016/j.humimm.2015.09.037

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  33 in total

1.  Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

2.  Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.

Authors:  Shih-Yao Chen; Ming-Fei Liu; Pin-Yu Kuo; Chrong-Reen Wang
Journal:  Clin Rheumatol       Date:  2019-02-15       Impact factor: 2.980

Review 3.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

4.  Chimeric Peptidomimetics of SOCS 3 Able to Interact with JAK2 as Anti-inflammatory Compounds.

Authors:  Sara La Manna; Laura Lopez-Sanz; Flavia Anna Mercurio; Sara Fortuna; Marilisa Leone; Carmen Gomez-Guerrero; Daniela Marasco
Journal:  ACS Med Chem Lett       Date:  2020-03-19       Impact factor: 4.345

5.  Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.

Authors:  Yan-Xia Wu; Wen-Li Zhang; Tong-Min Wang; Ying Liao; Yi-Jun Zhang; Ruo-Wen Xiao; Yi-Jing Jia; Zi-Yi Wu; Chang-Mi Deng; Da-Wei Yang; Wen-Qiong Xue; Yong-Qiao He; Xiao-Hui Zheng; Xi-Zhao Li; Ting Zhou; Pei-Fen Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Jiang-Bo Zhang; Wei-Hua Jia
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

6.  Compound heterozygous mutation of the ASXL3 gene causes autosomal recessive congenital heart disease.

Authors:  Fang Fu; Ru Li; Ting-Ying Lei; Dan Wang; Xin Yang; Jin Han; Min Pan; Li Zhen; Jian Li; Fa-Tao Li; Xiang-Yi Jing; Dong-Zhi Li; Can Liao
Journal:  Hum Genet       Date:  2020-07-21       Impact factor: 4.132

7.  A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.

Authors:  Daniel Ortega-Bernal; Claudia H González-De La Rosa; Elena Arechaga-Ocampo; Miguel Angel Alvarez-Avitia; Nora Sobrevilla Moreno; Claudia Rangel-Escareño
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

8.  Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response.

Authors:  Thomas Harwardt; Simone Lukas; Marion Zenger; Tobias Reitberger; Daniela Danzer; Theresa Übner; Diane C Munday; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2016-07-07       Impact factor: 6.823

Review 9.  Responses to Cytokines and Interferons that Depend upon JAKs and STATs.

Authors:  George R Stark; HyeonJoo Cheon; Yuxin Wang
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 9.708

10.  Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease.

Authors:  Jacqueline D Peda; Sally M Salah; Darren P Wallace; Patrick E Fields; Connor J Grantham; Timothy A Fields; Katherine I Swenson-Fields
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.